AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Moderna, Inc. Director's Dealing 2023

May 1, 2023

Director's Dealing

Opens in your device viewer

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2023-04-28

Reporting Person: NABEL ELIZABETH G (Director)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-04-28	Common Stock	M	670	—	Acquired	1373	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-04-28	Restricted Stock Units	$	M	670	Disposed		Common Stock (670)	Direct

F1: Restricted stock units convert into common stock on a one-for-one basis.

F2: The shares subject to this restricted stock unit award vested in full on April 28, 2023.